193 related articles for article (PubMed ID: 108345)
1. Minimal antibiotic concentrations of aminoglycosides and beta-lactam antibiotics for some gram-negative bacilli and gram-positive cocci.
Lorian V; De Freitas CC
J Infect Dis; 1979 May; 139(5):599-603. PubMed ID: 108345
[TBL] [Abstract][Full Text] [Related]
2. Determination of the range of antibacterial activity by use of viable counts.
Lorian V; Atkinson BA
J Clin Microbiol; 1982 Jul; 16(1):70-6. PubMed ID: 6809790
[TBL] [Abstract][Full Text] [Related]
3. Range of antibacterial activity of antibiotics at subminimal inhibitory concentrations: the ratio of minimal inhibitory concentration to minimal antibiotic concentration.
Ezrow L; Saceanu C; Dabydeen H
Rev Infect Dis; 1979; 1(5):821-4. PubMed ID: 396635
[TBL] [Abstract][Full Text] [Related]
4. [Studies on sub-MIC activities of beta-lactam antibiotics and aminoglycoside antibiotics against clinically isolated strain].
Takahashi M; Ichiman Y; Ohtomo T; Usui Y; Ohshima Y
Jpn J Antibiot; 1985 Dec; 38(12):3497-504. PubMed ID: 3938820
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
[TBL] [Abstract][Full Text] [Related]
6. In-vitro susceptibility of Pseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides.
Van der Auwera P; Schuyteneer F
J Antimicrob Chemother; 1983 Jun; 11(6):511-5. PubMed ID: 6411673
[TBL] [Abstract][Full Text] [Related]
7. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
[TBL] [Abstract][Full Text] [Related]
8. [New development on the field of antibiotic therapy].
Naumann P
Internist (Berl); 1975 Sep; 16(9):407-15. PubMed ID: 810448
[No Abstract] [Full Text] [Related]
9. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
11. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro].
De Rosa F; Tassi C; Stagni GR
Ann Sclavo; 1974; 16(1):65-72. PubMed ID: 4214247
[No Abstract] [Full Text] [Related]
12. Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
Watanakunakorn C; Glotzbecker C
J Antibiot (Tokyo); 1979 Oct; 32(10):1019-24. PubMed ID: 528361
[TBL] [Abstract][Full Text] [Related]
13. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
Schmid B; Kayser FH
Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
15. [Study on the antibacterial activity of penicillins and cephalosporines in urine (author's transl)].
Shah PM; Schirmer KP; Helm EB; Stille W
Arzneimittelforschung; 1976; 26(9):1636-8. PubMed ID: 826261
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the in vitro susceptibility of veterinary antibiotics with human antibiotics within aminoglycosides, β-lactam and fluoroquinolone antibiotic classes to highly resistant Gram-negative pathogens from human medicine.
Moore JE; Alcorn M; Rendall JC; Downey DG
Br J Biomed Sci; 2015; 72(3):146-9. PubMed ID: 26510272
[No Abstract] [Full Text] [Related]
17. In-vitro anti-microbial susceptibility of clinical isolates of pathogenic bacteria to ten antibiotics including phosphomycin.
Eke PI; Rotimi VO
Afr J Med Med Sci; 1987 Mar; 16(1):1-8. PubMed ID: 3037870
[TBL] [Abstract][Full Text] [Related]
18. [Effect of inhibitory (MIC) and subinhibitory concentrations of tobramycin on bacteriostatic and bactericidal activities of beta-lactam antibiotics (author's transl)].
Masuda G; Yajima T; Nakamura K; Yanagishita T; Yamazaki E
Jpn J Antibiot; 1979 Nov; 32(11):1189-95. PubMed ID: 117156
[No Abstract] [Full Text] [Related]
19. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
Melby K; Midtvedt T; Dahl O
Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
